Delgocitinib Cream Shows "Super Response" in Chronic Hand Eczema: Daily Dose
Your daily dose of the clinical news you may have missed.
Eisai Will Highlight Real-World Experience Data with Lecanemab at 2025 American Academy of Neurology Meeting
Data on use of lecanemab in real world clinical settings will come from a neurologic case series review and a retrospective chart review of long-term use, both in early AD.
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.
Nearly Half of Adults Diagnosed with MDD May Have Treatment Resistant Depression, Many Feel Hopeless
More than one-third of study participants with TRD had failed to get relief from 4 or more antidepressants, calling treatment experiences a "trial and error" process.
Maternal Mortality Due to Cardiovascular Disease More Than Doubles in the US
ACC 2025: Black women and women in Southern states faced significantly higher rates of maternal mortality, according to a new study.
America Leads High-Income Countries for Avoidable Deaths
Rates of preventable deaths are rising in every US state, according to a new study, defying the country's top-ranking spending on health care.
OX40 Inhibitor Rocatinlimab Found Effective for Atopic Dermatitis: Daily Dose
Does it Itch? Is it Painful? Is it Dry? Dermatoses Symptoms Don't Lie
Raj Chovatiya, MD, PhD, MSCI, actually said symptoms "never" lie so, particularly in patients with skin of color, if skin signs aren't clear, ask about the patient's experience.
Deadline Intervention Boosts Colorectal Cancer Screening Uptake: New Study
Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates, according to new research.
More Evidence that Women Face Greater CVD Risk than Men, Even When Baseline Health is Equal
For the same level of baseline health, the increase in risk related to each of 8 key CV risk factors appears significantly higher in women than in men.
Omlyclo Gains FDA Approval as Interchangeable Omalizumab Biosimilar: Daily Dose
Initial Treatment with Dual Statin + Ezetimibe Cuts All-Cause Mortality by 50%: New Meta-Analysis
The reductions observed in all-cause mortality (49%) and MACE (39%) in high-risk patients compared with statin monotherapy could be practice changing, researchers said.
Marijuana Use Tied to Increased Risk for Myocardial Infarction in People Aged 50 Years and Younger
Cannabis users had a more than sixfold increased risk of MI compared to non-users, according to a new study.
Does Skin Tone Affect Efficacy of Therapy for Atopic Dermatitis? Probably Not
AAD 2025: Raj Chovatiya, MD, PhD, MSCI, well-known physician scientist, says underrepresentation in clinical trials of those with skin of color precludes an evidence-based answer.
Early Amyloid Plaque Removal May Delay Alzheimer Disease Onset, A First-of-Its-Kind Study Suggests
In a small study of adults genetically predisposed to early-onset dementia, anti-amyloid treatment to remove plaque reduced risk of developing symptoms by 50%.
Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics
Researchers recommend expanding antimicrobial stewardship efforts to better track and reduce unnecessary antibiotic use.
Millions of US Adults Have Multiple Forms of Eczema, Study Finds
Nearly 1 in 10 US adults have eczema, with 18% experiencing multiple eczema conditions, researchers from the National Eczema Association reported.
The 10 States with the Highest Risk for Cancer
The greatest risk for developing cancer faces residents of South Dakota, where radon levels are the nation's highest, and ranks for alcohol consumption and obesity are poor.
Guselkumab (Tremfya) Wins Approval for Crohn Disease, Fourth Indication for Immune-Mediated Diseases
The IL-23 inhibitor is the only drug in the class available with both subcutaneous and intravenous administration options for treatment induction, according to J&J.
Investigational Keto Diet Pill Shows Promise in Phase 1 Trial: Daily Dose
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Millions of US Adults Have Multiple Forms of Eczema, Study Finds")
